Skip to main content

Table 1 Overview of parameters (median (25th–75th percentiles) and # median (25th percentile)) between coronavirus disease 2019 (COVID-19) patients with and without EBV viremia and non-COVID-19 patients

From: Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19

  COVID-19 (n = 18) COVID-19
EBV negative (n = 4)
COVID-19
EBV positive (n = 14)
Non-COVID-19
(n = 18)
Age (years) 60.5
(52.0–64.5)
45.5
(43.3–59.0)
61.5
(53.8–66.8)
58.8
(47.8–72.3)
IL-6 (ng/l) 125.1
(40.5–302.8)
20.9
(18.0–101.4)
142.0
(106.0–342.4)
85.7
(43.6–377.4)
CRP (mg/dl) 14.6
(4.3–16.6)
5.8
(2.2–14.8)
15.5
(7.7–19.7)
8.3
(3.7–28.1)
PCT (µg/l) 0.3
(0.2–0.8)
0.2
(0.1–0.4)
0.4
(0.2–1.1)
1.3
(0.2–6.8)
Bilirubin total (mg/dl) 0.9
(0.4–1.2)
0.67
(0.4–0.9)
1.0
(0.4–1.3)
0.7
(0.5–2.6)
ASAT (U/l) 67.5
(33.5–91.8)
63.0
(18.8–114.0)
67.5
(33.5–85.8)
51.0
(38.5–122.3)
ALAT (U/l) 49.0
(37.5–80.5)
73.5
(20.5–185.75)
49.0
(40.5–72.3)
56.0
(23.8–194.8)
GGTP (U/l) 173.0
(61.5–370.0)
206.5
(8.8–657.0)
151.5
(60.3–370.0)
131.5
(76.5–305.0)
AP (U/l) 103.5
(79.0–222.0)
131.0
(102.3–273.8)
93.0
(57.3–222.0)
220.5
(175.5–559.3)
Amylase (U/l) 37.0
(24.5–67.0)
37.0
(22.0)#
43.0
(23.3–71.8)
39.0
(15.0–48.0)
Lipase (U/l) 43.0
(21.0–75.0)
26.0
(26.0)#
47.5
(19.3–74.0)
30.0
(16.0–66.0)
  1. EBV, Epstein–Barr virus; ICU, intensive care unit; IL-6, interleukin-6; PCT, procalcitonin; CRP, c-reactive protein; ASAT, aspartate aminotransferase; ALAT, alanine aminotransferase; GGTP, gamma glutamyltransferase; AP, alkaline phosphatase